We describe a rare complication of stereotactic radiotherapyfo r large acoustic neuromas in a pat ient with type 2 neurofibromatosis. We retrospectively reviewed the case ofa 14-year-old girl who had been referred to our tertiary care center. Prior to ref erral, the patient had been evaluatedfor hoarseness. During the work-up, magnetic resonanc e imaging (MRl) detected two large bilateral acousti c neuromas and two bilateral ju gular f oramen tumo rs. The patient was diagnosed with type 2 neurofibromato sis, and she underwent stereotactic radiotherapy f or treatment of the two acoustic neuromas; the ju gular foram en tumors were not irradiated. The pati ent' s post-treatment course was complicated by hydrocephalu s and symptoms of brainstem compression, which required urgent surgical intervention. Follow-up MRI 7 months foll owing radiotherapy demonstrated a rapid growth of the acoustic neuromas, but no appreciable change in the size of the ju gular f oramen neuromas. These findin gs suggest that the radiotherapy might have been the cause of the rapid growth of the acoustic neuromas. To our knowledge, no such report has been publish ed in the literature, and this phenomenon might be unique. Our findin gs suggest that radiotherapy might not be the optimalfi rst-line treatment fo r acoustic neuromas in pati ents with type 2 neurofibromatosis.
Introduction
Stereotactic radioth erapy has been advocated as an alternative to microsurgical removal of acoustic neuromas. Gamma units, linear accelerators, and cyclotron acceler ators have all been used to generate a focused radiation beam directed at the center of the targeted tumor. In 1971, Leksell was the first to report the efficacy of this technique .' Since then, several authors have described the outcomes of patients whose acoustic neuromas were treated in this manner. [2] [3] [4] They reported that the complication rates associated with stereotactic radiotherapy with regard to facial palsy and hearing loss were similar to those seen with microsurgical techniqu es.
Stereotactic radiotherapy has also been used for the treatm ent of bilateral acoustic neuromas in patients with type 2 neurofibromatosis (NF2). The reported rate of hearin g preservation in these patients appears to be better than that seen with microsurgical resection.' However, data on long-term follow-up and detailed post-treatment compl ications are lacking.
In this article, we report a rare-perhaps unique--case of rapid tumor growth following stereotactic radiotherapy in a patient with NF2. A compari son of the growth rates of the patient's treated acoustic neurom as with the growth rates of the adjacent untreated jugular foramen neurom as strongly suggests that irradiation might have been the cause of the rapid growth of the former. The patient' s postirradiation course was also fraught with a series of compli cations, which illustrates the sometimes difficult nature of stereotactic radiotherapy.
Case report
A previou sly healthy 14-year-old girl had been evaluated for hoarseness. A right vocal fold impairment was noted on physic al examination. Magnetic resonance imaging (MRI) detected multip le intracrani al lesions that were consistent with NF2. There were two bilateral acoustic neurom as, which measured 1.5 x 2.0 ern on the left and 1.0 x 1.5 em on the right, and two bilateral ju gular foramen neurom as, which measured 1.5 x 1.5 em on the left and 1.0 x 1.0 ern on right (figure 1). Shortly after the MRI results were reviewed, the patient was referred to our tertiary care cente r.
Surprisingly, audiom etric testing revealed that the patient's hearing was normal ; on the right , her speech reception threshold was adB and her speech discrimination score was 96%; the corresponding figures on the left were 5 dB and 96%. The surgeon recommended microsurgical removal of the larger left cerebellopontine angle lesion and concurrent decompression of the left jugular foramen tumor . However, the patient's family chose stereotactic radiotherapy instead. A total of 22 Gy was delivered in fractionated doses to both cerebellopontine angle masse s; the dose to the tumor periphery averaged 18 Gy. The jugular foramen lesions were spared . Three month s following stereotactic radiotherapy, the patient developed hydrocephalus, which required placement of a ventriculoperitoneal shunt. Seven month s after radiotherapy, the patient returned with acute lethargy, ataxia , confusion, and hallucinations. MRI examination revealed that the acoustic neuromas had grown markedly and measured 2.5 x 3.5 em on the left and 2.0 x 2.0 em on the right (figure 2). The size of the jugular foramen neuromas remained stable, measuring 1.6 x 1.5 em on the left and 1.0 x 1.0 em on the right. Moreover, the brainstem compression was noted to have increased significantly compared with the findings on the initial MRI.
The patient underwent emergency surgery via a left suboccipital approach to decompress the enlarged tumor and to relieve the brainstem compression. However, during manipulation of the tumor , the patient went into cardiac arrest. She was resuscitated, and the procedure
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A B RAPID GROWTH OF ACOUSTIC NEURO MAS AFTER STEREOTACT IC RADIOT HERAPY IN TYPE 2 NEUROFIBROMATOSIS was termin ated. Four days later, she was returned to the operating room for successful debulkin g of the tumor from the brainstem. Pathologi c analysis revealed viable tumor cells that were consistent with acoustic neuroma .
Postoperatively, extubation failed, and the patient developed right lower lobe pneumonia. Despite aggressive medical therapy, she developed sepsis and died on postoperative day 6.
Discussion
This case represe nts an unusual outcome of radiotherapy : an accelerated growth of acoustic neuromas . The expected outcome following radiotherapy for sporadic acoustic neuromas is cessation of tumor growth, which has been reported to have occurred in 43 to 74% of cases over a 3year follow-up.>!" Continued slow growth was reported in up to 12% of cases . 5 
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Only a few studies have focused on the efficacy of radiotherapy in NF2 patients who have bilateral acoustic neuromas. A direct comparison of the response rates in NF2 patients and non-NF2 patients suggests that NF2 patients are twice as likely to experience slow persistent tumor growth after radiotherapy (12 vs 24%). 8 Rapid growth of an acoustic neuroma follow ing radiotherapy has not been reported to date. This case suggests the possibility that the rapid growth seen in our patient was actually induced by radiotherapy. Supporti ng this hypothesis is the fact that the nonirradiated jugular foramen neuromas-which are histologically similar to acoustic neuromas-grew only minimally during the same time.
This case also illustrates the potential danger of using radiotherapy to treat NF2-associated acoustic neuromas that are compressing the brainstern. The proximity of these tumors to the brainstem indicates that any tumor expansion will result in further brainstem compression and significan t morbidity . Slight tumor expansion following radiotherapy has been observed within 6 months of therapy .II In this respect, the presence of bilateral acoustic neuromas in NF2 patient s would confer a higher risk of further brainstem compression. Additionally, radiotherapy for NF2-associated acoustic neuromas is associated with a higher rate of persistent tumor growth than is radiotherapy for sporadic acoustic neuromas. " These two factor s argue against the use of radiotherapy as the primary treatment modality for NF2 patients with acoustic neuroma s that are already compressing the brainstem. Stereotactic radiotherapy is not necessarily a benign treatment for these patients.
